Fresca Medical, Inc. Completes Initial Close of Series C Preferred Stock Financing

Fresca Medical, Inc.

Represented Fresca Medical, Inc. with the initial close of its Series C Preferred Stock financing, raising $3.6 million of an anticipated total financing of $6 million. Vincent Medical, Inc. acted as lead investor.

Fresca Medical Inc, a Delaware corporation, specializes in developing medical devices for the treatment of sleep apnea. Vincent Medical, Inc. is a Hong Kong-based company that manufactures a wide range of medical devices for major international and medical device companies.

The Newport Beach-based deal team representing Fresca Medical included Bruce Feuchter and Jeff Estes.